Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • YENTREVE ® - Depressive Disorder, Major
    Clinical Study Number 1208.24
    Study Indication Depressive Disorder, Major
    Product YENTREVE ®
    Generic Name Duloxetine
    Lab Code
    Clinical Phase IV
    Study Title

    An eight-week, randomized, double-blind, two parallel groups, study to assess clinical response of duloxetine 60 mg and 120 mg per day in patients hospitalized for severe depression.

    Study Document
    Trial synopsis 1208.24_DR english
  • YENTREVE ® - Depressive Disorder, Major
    Clinical Study Number 1208.10
    Study Indication Depressive Disorder, Major
    Product YENTREVE ®
    Generic Name Duloxetine
    Lab Code
    Clinical Phase IIIb
    Study Title

    A ten-week, randomized, double-blind study evaluating the efficacy of duloxetine 60 mg once daily versus placebo in outpatients with major depressive disorder and pain (EU-Pain enriched study)

    Study Document
    Trial synopsis 1208.10 english